THE PHARMACIST'S ROLE IN PAVING THE TREATMENT SUCCESS PATHWAY FOR SCHIZOPHRENIA- Differentiate safety, efficacy, pharmacokinetics (PK), and adherence data for the agents used in the long-term maintenance of schizophrenia. Discuss healthcare decision-making and motivation among schizophrenia patients and healthcare providers. Recommend interventions to HCPs that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs. Perform interventions for schizophrenia patients that will improve appropriate access to, and use of, antipsychotic medication, including use of LAIs.
1.0 Free CEUs for Pharmacists
Expires 6/16/15
Jointly sponsored by RMEI, LLC and The College of Psychiatric and Neurologic Pharmacists. RMEI gratefully acknowledges an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck in support of this CPE activity.